Gutsy Opinion

It was refreshing to read T.V. Rajan's Opinion in the April 29, 1996, issue of The Scientist ("Cause Of Current Funding Crisis May Lie In De-emphasis Of Scholarship," page 10). Most impressive is to see someone with enough guts to admit and detail some of the problems already outlined by many of us. The situation hurts us all, and one way or the other I am sure opinionated investigators will be punished for opening their big mouths, even in this free society. However, anyone with a clear consc

Written byCesar Fermin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

It was refreshing to read T.V. Rajan's Opinion in the April 29, 1996, issue of The Scientist ("Cause Of Current Funding Crisis May Lie In De-emphasis Of Scholarship," page 10). Most impressive is to see someone with enough guts to admit and detail some of the problems already outlined by many of us.

The situation hurts us all, and one way or the other I am sure opinionated investigators will be punished for opening their big mouths, even in this free society. However, anyone with a clear conscience and a bit of knowledge about the issues at stake at study sections knows that, as Rajan nicely stated, ". . . who gets funded and who does not is ludicrously capricious." Quoting Rajan again, ". . . a typically excruciating discussion of the most minute and insignificant details of a grant proposal . . ." ensues, probably, as he puts it, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies